Welcome
Support Centre
12 February 2012 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
mental health register
archived registers
all registers
tips on searching
 
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
The role of Oxidant Stress on the induction of the Inflammatory Reaction by Cardiopulmonary Bypass
Source of recordUK Trials
ISRCTNISRCTN76622877
Date ISRCTN assigned30/09/2004
Local reference number(s)N0123138565
Public titleThe role of Oxidant Stress on the induction of the Inflammatory Reaction by Cardiopulmonary Bypass
Scientific title
AcronymN/A
Disease/condition/study domainSurgery: Cardiovascular
Study hypothesis1. To study the mechanism by which inflammatory response to cardiopulmonary bypass is modulated by oxidant stress
2. To use an ex-vivo model of cardiopulmonary bypass (CPB) and blood samples from patients to investigate oxygen free radicals on the pathogenesis
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteriaPatients with ischaemic heart disease (IHD) scheduled for elective cardiac operations will be selected.
Participants - exclusion criteriaNot provided at time of registration
Patient information material
Anticipated start date05/12/2003
Anticipated end date30/09/2006
Status of trialCompleted
Target number of participantsNot provided at time of registration
InterventionsThe project is composed of laboratory based investigation and the molecular changes associated with the re-circulation of blood in an artificial surface will be studied using a surrogate model of CPB. A total of 400 patients will be randomised to one of the groups: IHD with and without Hypertension, IHD with and without Hypercholesterolemia, IHD with and without Diabetes, Healthy control.
Primary outcome measure(s)Proinflammatory cytokines, antioxidant capacity, oxygen free radicals and clinical outcomes.
Secondary outcome measure(s)Not provided at time of registration
Sources of fundingUniversity Hospitals of Leicester NHS Trust (UK)
Sponsor nameRecord Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)
Sponsor detailsThe Department of Health, Richmond House, 79 Whitehall
London
United Kingdom
SW1A 2NL
Sponsor telephone+44 (0)20 7307 2622
Sponsor emaildhmail@doh.gsi.org.uk
Sponsor websitehttp://www.dh.gov.uk/Home/fs/en
Contact nameDr B Matata
Contact detailsUniversity Hospitals of Leicester
c/o Research and Development Office
Leicester General Hospital NHS Trust
Leicester
United Kingdom
LE1 4PW
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN76622877
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement


BioMed Central